Skip to main content

Advertisement

SpringerLink
Log in

Demyelinating disorders: Update on transverse myelitis

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Transverse myelitis (TM) is a focal inflammatory disorder of the spinal cord. Perivascular monocytic and lymphocytic infiltration, demyelination, and axonal injury are prominent histopathogic features of TM. The clinical manifestations of TM are consequent to dysfunction of motor, sensory, and autonomic pathways. At peak deficit, 50% of patients with TM are completely paraplegic (with no volitional movements of legs), virtually all have some degree of bladder dysfunction, and 80% to 94% have numbness, paresthesias, or band-like dysesthesias. Longitudinal case series of TM reveal that approximately one third of patients recover with little to no sequelae, one third are left with a moderate degree of permanent disability, and one third have severe disability. Recent studies have shown that the cytokine interleukin-6 may be a useful biomarker, as the levels of interleukin-6 in the cerebrospinal fluid of acute TM patients strongly correlate with and are highly predictive of disability. Clinical trials testing the efficacy of promising axonoprotective agents in combination with intravenous steroids in the treatment of TM are currently underway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Berman M, Feldman S, Alter M, et al.: Acute transverse myelitis: incidence and etiologic considerations. Neurology 1981, 31:966–971.

    PubMed  CAS  Google Scholar 

  2. Transverse Myelitis Consortium Working Group: Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002, 59:499–505. This manuscript established a new set of criteria for TM that distinguished it from noninfkammatory myelopathies and distinguished idiopathic TM from TM associated with either systemic inflammatory disease or from multifocal CNS disease.

    Google Scholar 

  3. Achiron A, Barak Y: Multiple sclerosis-from probable to definite diagnosis: a 7-year prospective study. Arch Neurol 2000, 57:974–979.

    Article  PubMed  CAS  Google Scholar 

  4. Jeffery DR, Mandler RN, Davis LE: Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 1993, 50:532–535.

    PubMed  CAS  Google Scholar 

  5. Christensen PB, Wermuth L, Hinge HH, Bomers K: Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol Scand 1990, 81:431–435.

    Article  PubMed  CAS  Google Scholar 

  6. Altrocchi PH: Acute transverse myelopathy. Arch Neurol 1963, 9:21–29.

    Google Scholar 

  7. Paine RS, Byers RK: Transverse myelopathy in childhood. AMA Am J Dis Child 1968, 85:151–163.

    Google Scholar 

  8. Knebusch M, Strassburg HM, Reiners K: Acute transverse myelitis in childhood: nine cases and review of the literature. Dev Med Child Neurol 1998, 40:631–639.

    Article  PubMed  CAS  Google Scholar 

  9. Dunne K, Hopkins IJ, Shield LK: Acute transverse myelopathy in childhood. Dev Med Child Neurol 1986, 28:198–204.

    Article  PubMed  CAS  Google Scholar 

  10. Sakakibara R, Hattori T, Yasuda K, Yamanishi T: Micturition disturbance in acute transverse myelitis. Spinal Cord 1996, 34:481–485.

    PubMed  CAS  Google Scholar 

  11. Burns AS, Rivas DA, Ditunno JF: The management of neurogenic bladder and sexual dysfunction after spinal cord injury. Spine 2001, 26:S129-S136.

    Article  PubMed  CAS  Google Scholar 

  12. DasGupta R, Fowler CJ: Sexual and urological dysfunction in multiple sclerosis: better understanding and improved therapies. Curr Opin Neurol 2002, 15:271–278.

    Article  PubMed  Google Scholar 

  13. Patten SB, Metz LM: Depression in multiple sclerosis. Psychother Psychosom 1997, 66:286–292.

    Article  PubMed  CAS  Google Scholar 

  14. Hummers LK, Krishnan C, Casciola-Rosen L, et al.: Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology 2004, 62:147–149.

    PubMed  CAS  Google Scholar 

  15. Ropper AH, Poskanzer DC: The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol 1978, 4:51–59.

    Article  PubMed  CAS  Google Scholar 

  16. Irani DN, Kerr DA: 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis. Lancet 2000, 355:901.

    Article  PubMed  CAS  Google Scholar 

  17. Nagaswami S, Kepes J, Foster DB, Twemlow SW: Necrotizing myelitis: a clinico-pathologic report of two cases associated with diplococcus pneumoniae and mycoplasma pneumoniae infections. Trans Am Neurol Assoc 1973, 98:290–292.

    PubMed  CAS  Google Scholar 

  18. Mirich DR, Kucharczyk W, Keller MA, Deck J: Subacute necrotizing myelopathy: MR imaging in four pathologically proved cases. Am J Neuroradiol 1991, 12:1077–1083.

    PubMed  CAS  Google Scholar 

  19. Katz JD, Ropper AH: Progressive necrotic myelopathy: clinical course in 9 patients. Arch Neurol 2000, 57:355–361.

    Article  PubMed  CAS  Google Scholar 

  20. Brocke S, Hausmann S, Steinman L, Wucherpfennig KW: Microbial peptides and superantigens in the pathogenesis of autoimmune diseases of the central nervous system. Semin Immunol 1998, 10:57–67.

    Article  PubMed  CAS  Google Scholar 

  21. Kaplin AI, Krishnan C, Deshpande DM, et al.: Diagnosis and management of acute myelopathies. Neurologist 2005, 11:2–18. This review article provides details on the paraclinical and clinical features of a large cohort of patients with TM and presents some of the pathologic features of TM.

    Article  PubMed  Google Scholar 

  22. Elovaara I, Lalla M, Spare E, et al.: Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS. Neurology 1998, 51:1703–1708.

    PubMed  CAS  Google Scholar 

  23. Sellebjerg F, Christiansen M, Jensen J, Frederiksen JL: Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis. Eur J Neurol 2000, 7:281–289.

    Article  PubMed  CAS  Google Scholar 

  24. Bracken MB, Shepard MJ, Collins WF, et al.: A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990, 322:1405–1411.

    Article  PubMed  CAS  Google Scholar 

  25. Defresne P, Meyer L, Tardieu M, et al.: Efficacy of high dose steroid therapy in children with severe acute transverse myelitis. J Neurol Neurosurg Psychiatry 2001, 71:272–274.

    Article  PubMed  CAS  Google Scholar 

  26. Lahat E, Pillar G, Ravid S, et al.: Rapid recovery from transverse myelopathy in children treated with methylprednisolone. Pediatr Neurol 1998, 19:279–282.

    Article  PubMed  CAS  Google Scholar 

  27. Sebire G, Hollenberg H, Meyer L, et al.: High dose methylprednisolone in severe acute transverse myelopathy. Arch Dis Child 1997, 76:167–168.

    Article  PubMed  CAS  Google Scholar 

  28. Kalita J, Misra UK: Is methyl prednisolone useful in acute transverse myelitis? Spinal Cord 2001, 39:471–476.

    Article  PubMed  CAS  Google Scholar 

  29. Weinshenker BG: Plasma exchange for severe attacks of inflammatory demyelinating diseases of the central nervous system. J Clin Apheresis 2001, 16:39–42. This manuscript is one of several from the same group showing that plasma exchange is effective in severe CNS inflammatory disorders.

    Article  PubMed  CAS  Google Scholar 

  30. Weinshenker BG: Therapeutic plasma exchange for acute inflammatory demyelinating syndromes of the central nervous system. J Clin Apheresis 1999, 14:144–148.

    Article  PubMed  CAS  Google Scholar 

  31. Weinshenker BG, O’Brien PC, Petterson TM, et al.: A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999, 46:878–886.

    Article  PubMed  CAS  Google Scholar 

  32. Keegan M, Pineda AA, McClelland RL, et al.: Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002, 58:143–146. After the initial study, which showed that plasma exchange is effective in monosymptomatic CNS inflammatory disorders, this study defined clinical characteristics that predicted who responded to it.

    Article  PubMed  CAS  Google Scholar 

  33. Wollinsky KH, Hulser PJ, Brinkmeier H, et al.: CSF filtration is an effective treatment of Guillain-Barre syndrome: a randomized clinical trial. Neurology 2001, 57:774–780. This is a novel study examining cerebrospinal fluid filtration in patients with Guillain-Barré syndrome compared with the accepted therapy, plasma exchange. The exciting finding was that cerebrospinal fluid filtration—accomplished by repeated exchange through a filter designed to remove cells, bacteria, endotoxins, immunoglobulins, and inflammatory mediators—is as effective as plasma exchange. If confirmed in larger studies, this would represent a major advance. Conceptually, this treatment would potentially be even more effective in patients with acute transverse myelitis.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Johns Hopkins University School of Medicine, Pathology 627, 600 North Wolfe Street, 21287-6965, Baltimore, MD, USA

    Sanjay C. Keswani MBBS, MRCP

Authors
  1. Chitra Krishnan MHS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adam I. Kaplin MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carlos A. Pardo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Douglas A. Kerr MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sanjay C. Keswani MBBS, MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanjay C. Keswani MBBS, MRCP.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krishnan, C., Kaplin, A.I., Pardo, C.A. et al. Demyelinating disorders: Update on transverse myelitis. Curr Neurol Neurosci Rep 6, 236–243 (2006). https://doi.org/10.1007/s11910-006-0011-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-006-0011-1

Keywords

Search

Navigation